Literature DB >> 29997096

[Infiltrating mast cells promote neuroendocrine differentiation and increase docetaxel resistance of prostate cancer cells by up-regulating p21].

Yi-Hong Ou1, Yao-Dong Jiang, Qi Li, Yong-Jiang Zhuang, Qiang Dang, Wan-Long Tan.   

Abstract

OBJECTIVE: To investigate the effect of infiltrating mast cells on neuroendocrine differentiation (NED) and docetaxel sensitivity of prostate cancer (PCa) cells in vitro.
METHODS: Human PCa cell lines (LNCaP and C4-2) were co-cultured with human mast cell line (HMC-1) in Transwell chambers. Androgen receptor (AR) was silenced in C4-2 cells using sh-AR lentivirus, and p21 was knocked down and overexpressed by transfecting C4-2 cells with pLKO.1-sh-p21 and pCMV-p21, respectively. The morphological changes of LNCaP and C4-2 cells were observed. MTT assay and colony formation assay were used to assess the proliferation of LNCaP and C4-2 cells. CCK8 assay was used to detect the cell viability of C4-2 cells following docetaxel trreatment. RT-qPCR and Western blotting were performed to determine the mRNA and protein expressions of neuroendocrine markers, AR and p21 in the cells.
RESULTS: Co-culture with HMC-1 cells enhanced the neuroendocrine phenotypes, inhibited the proliferation and up-regulated the expression of p21 in LNCaP and C4-2 cells. P21 positively regulated NED through a non-AR-dependent signaling pathway, while p21 knockdown partially reversed NED promoted by the mast cells. PCa cells co-cultured with HMC-1 cells showed increased resistance to docetaxel, and silencing p21 partially reversed docetaxel resistance in PCa cells.
CONCLUSION: Infiltrating mast cells up-regulates p21 to promote NED and increase docetaxel resistance in PCa cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29997096      PMCID: PMC6765720     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  28 in total

Review 1.  Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies.

Authors:  Vincenza Conteduca; Michele Aieta; Dino Amadori; Ugo De Giorgi
Journal:  Crit Rev Oncol Hematol       Date:  2014-05-27       Impact factor: 6.312

2.  Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin.

Authors:  N Xing; J Qian; D Bostwick; E Bergstralh; C Y Young
Journal:  Prostate       Date:  2001-06-15       Impact factor: 4.104

3.  Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.

Authors:  Miika Sainio; Tapio Visakorpi; Teemu Tolonen; Joanna Ilvesaro; G Steven Bova
Journal:  Pathol Res Pract       Date:  2018-04-26       Impact factor: 3.250

4.  Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.

Authors:  Thomas Fixemer; Klaus Remberger; Helmut Bonkhoff
Journal:  Prostate       Date:  2002-10-01       Impact factor: 4.104

5.  Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1.

Authors:  Mayuko Kanayama; Toshiya Hayano; Michinori Koebis; Tatsuya Maeda; Yoko Tabe; Shigeo Horie; Atsu Aiba
Journal:  Prostate       Date:  2017-09-14       Impact factor: 4.104

6.  Attenuation of apoptosis by chromogranin A-induced Akt and survivin pathways in prostate cancer cells.

Authors:  Junyang Gong; JuneGoo Lee; Horiguchi Akio; Peter N Schlegel; Ruoqian Shen
Journal:  Endocrinology       Date:  2007-06-21       Impact factor: 4.736

Review 7.  Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis.

Authors:  Hai Tao Wang; Yan Hong Yao; Bao Guo Li; Yong Tang; Ji Wu Chang; Jiao Zhang
Journal:  J Clin Oncol       Date:  2014-09-15       Impact factor: 44.544

8.  Neuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling.

Authors:  John O DaSilva; George P Amorino; Eli V Casarez; Bradley Pemberton; Sarah J Parsons
Journal:  Prostate       Date:  2012-11-28       Impact factor: 4.104

9.  Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.

Authors:  Lei Li; Qiang Dang; Hongjun Xie; Zhao Yang; Dalin He; Liang Liang; Wenbing Song; Shuyuan Yeh; Chawnshang Chang
Journal:  Oncotarget       Date:  2015-06-10

10.  Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling.

Authors:  T-H Lin; K Izumi; S O Lee; W-J Lin; S Yeh; C Chang
Journal:  Cell Death Dis       Date:  2013-08-08       Impact factor: 8.469

View more
  1 in total

Review 1.  Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play.

Authors:  Girijesh Kumar Patel; Natasha Chugh; Manisha Tripathi
Journal:  Cancers (Basel)       Date:  2019-09-20       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.